News
Chet Borgida Elected To Board of Directors
St. Petersburg, Florida - October 18, 2007—MTS Medication Technologies, Inc. (AMEX:MPP) (www.mts-mt.com) announced today that Chet Borgida, has been elected to its Board of Directors. Mr. Borgida has more than 40 years of domestic and international experience in advising retail, distribution, media and other businesses.
Mr. Borgida joined Arthur Andersen & Company in 1967, and through 1975, his engagements included the audits of many large global companies. In 1975, he joined Grant Thornton LLP, MTS’s Independent Auditors, and was admitted to the partnership in 1977. In addition, Mr. Borgida was Partner-in-Charge of Grant Thornton’s Long Island office as well as the founder and National Director of the Capital Markets Group. Mr. Borgida retired from Grant Thornton in 2001 and joined Cross Media Marketing and served as Chief Financial Officer until 2003. From 2006 through 2007, Mr. Borgida served as Chief Operating Officer of Naples Realty Group, LLC. While at Grant Thornton, Mr. Borgida had no involvement in the review or examination of MTS’s financial statements.
Mr. Borgida serves as a Director and Audit Committee Chair of Warren Resources, Inc. He also served as a Director and Audit Committee Chair of Correctional Services Corporation from 2002 through the sale of the company in 2005. Mr. Borgida is a Certified Public Accountant in New York and Florida and a member of the AICPA.
About MTS Medication Technologies
Founded in 1984, MTS Medication Technologies (www.mts-mt.com) is an international provider of medication compliance packaging systems designed to improve medication dispensing and administration. MTS manufactures automated packaging machines and related consumables for prescription medications and nutritional supplements. The Company serves more than 8,000 pharmacies worldwide.